IGHV Mutational Status in a Cohort of Bulgarian CLL Patients: High Unmutated CLL Prevalence in North-East Bulgaria

1. Rajendra ND, Tarun W, Franco F et al. Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia, Blood, Volume 94, Issue 6, 1999, Pages 1840–1847. RajendraND TarunW FrancoF Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia Blood 94 6 1999 1840 1847 Search in Google Scholar

2. Sutton, L. A., et al. Immunoglobulin genes in chronic lymphocytic leukemia: Key to understanding the disease and improving risk stratification. Haematologica. 102 (6), 968–971 (2017). SuttonL. A. Immunoglobulin genes in chronic lymphocytic leukemia: Key to understanding the disease and improving risk stratification Haematologica 102 6 968 971 2017 Search in Google Scholar

3. Ten Hacken E, Gounari M, Ghia P et al. The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia. Leukemia. 2019 Feb;33(2):287–298. doi: 10.1038/s41375-018-0303-x. Epub 2018 Dec 16. PMID: 30555163; PMCID: PMC7182338. Ten HackenE GounariM GhiaP The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia Leukemia 2019 Feb 33 2 287 298 10.1038/s41375-018-0303-x Epub 2018 Dec 16. 30555163 PMC7182338 Open DOISearch in Google Scholar

4. Schroeder HW Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S41–52. doi: 10.1016/j.jaci.2009.09.046. PMID: 20176268; PMCID: PMC3670108 SchroederHWJr CavaciniL Structure and function of immunoglobulins J Allergy Clin Immunol 2010 Feb 125 2 Suppl 2 S41 52 10.1016/j.jaci.2009.09.046 20176268 PMC3670108 Open DOISearch in Google Scholar

5. Calis JJ, Rosenberg BR. Characterizing immune repertoires by high throughput sequencing: strategies and applications. Trends Immunol. 2014;35(12):581–590. CalisJJ RosenbergBR Characterizing immune repertoires by high throughput sequencing: strategies and applications Trends Immunol 2014 35 12 581 590 Search in Google Scholar

6. Agathangelidis A, Chatzidimitriou A, Chatzikonstantinou T et al. Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL. Leukemia 2022; 36, 1961–1968. AgathangelidisA ChatzidimitriouA ChatzikonstantinouT Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL Leukemia 2022 36 1961 1968 Search in Google Scholar

7. Huet, Sarah & Bouvard, Anne & Ferrant, Emmanuelle & Mosnier, Isabelle & Chabane, Kaddour & Salles, Gilles & Michallet, Anne-Sophie & Hayette, Sandrine & Sujobert, Pierre. (2020). Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia. Leukemia. 34. 10.1038/s41375-020-0716-1. HuetSarah BouvardAnne FerrantEmmanuelle MosnierIsabelle ChabaneKaddour SallesGilles MichalletAnne-Sophie HayetteSandrine SujobertPierre 2020 Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia Leukemia 34 10.1038/s41375-020-0716-1 Open DOISearch in Google Scholar

8. Agathangelidis A, Sutton LA, Hadzidimitriou A et al. Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation. 2018 J. Vis. Exp. (141) AgathangelidisA SuttonLA HadzidimitriouA Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation 2018 J. Vis. Exp. 141 Search in Google Scholar

9. Matthews C, Catherwood M, Morris TC et al. Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols. Leuk Lymphoma. 2004 Sep;45(9):1899–904. MatthewsC CatherwoodM MorrisTC Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols Leuk Lymphoma 2004 Sep 45 9 1899 904 Search in Google Scholar

10. Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W503–8. BrochetX LefrancMP GiudicelliV IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis Nucleic Acids Res 2008 Jul 1 36 Web Server issue W503 8 Search in Google Scholar

11. Jain P, Nogueras Gonzalez GM, Kanagal-Shamanna R. The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab. Br J Haematol. 2018; 180(1):33–40. JainP Nogueras GonzalezGM Kanagal-ShamannaR The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab Br J Haematol 2018 180 1 33 40 Search in Google Scholar

12. Darzentas N. ARResT/Interrogate Immunoprofiling Platform: Concepts, Workflows, and Insights. 2022 May 28. In: Langerak AW, editor. Immunogenetics: Methods and Protocols [Internet]. New York: Humana; 2022. Chapter 26. Available from: https://www.ncbi.nlm.nih.gov/books/NBK586953/ doi: 10.1007/978-1-0716-2115-8_26; DarzentasN ARResT/Interrogate Immunoprofiling Platform: Concepts, Workflows, and Insights 2022 May 28 In: LangerakAW editor. Immunogenetics: Methods and Protocols [Internet] New York Humana 2022 Chapter 26. Available from: https://www.ncbi.nlm.nih.gov/books/NBK586953/ 10.1007/978-1-0716-2115-8_26 Open DOISearch in Google Scholar

13. Bystry V, Agathangelidis A, Bikos V et al, also on behalf of ERIC, the European Research Initiative on CLL, ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy, Bioinformatics, Volume 31, Issue 23, December 2015, Pages 3844–3846, BystryV AgathangelidisA BikosV also on behalf of ERIC, the European Research Initiative on CLL ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy Bioinformatics 31 23 December 2015 3844 3846 Search in Google Scholar

14. Gaidano G, Rossi D. The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):329–337. doi: 10.1182/asheducation-2017.1.329. PMID: 29222275; PMCID: PMC6142556. GaidanoG RossiD The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment Hematology Am Soc Hematol Educ Program 2017 Dec 8 2017 1 329 337 10.1182/asheducation-2017.1.329 29222275 PMC6142556 Open DOISearch in Google Scholar

15. Hanson C. GHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL). Available from: https://news.mayocliniclabs.com/2019/08/12/ighv-and-tp53-sequencing-clinical-utility-in-chronic-lymphocytic-leukemia-cll HansonC GHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) Available from: https://news.mayocliniclabs.com/2019/08/12/ighv-and-tp53-sequencing-clinical-utility-in-chronic-lymphocytic-leukemia-cll Search in Google Scholar

16. Plevova K, Francova HS, Burckova K et al. Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clones. Haematologica. 2014 Feb;99(2):329–38. PlevovaK FrancovaHS BurckovaK Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clones Haematologica 2014 Feb 99 2 329 38 Search in Google Scholar

17. Rotbain EC, Frederiksen H, Hjalgrim H, et al. IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study. Haematologica. 2020 Jun;105(6):1621–1629 RotbainEC FrederiksenH HjalgrimH IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study Haematologica 2020 Jun 105 6 1621 1629 Search in Google Scholar

18. Gemenetzi K, Agathangelidis A, Zaragoza-Infante L et al. B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making; Frontiers in Oncology 10, 2020; GemenetziK AgathangelidisA Zaragoza-InfanteL B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making Frontiers in Oncology 10 2020 Search in Google Scholar